A Revised CAO Staging Classification to Predict the Prognosis of Acquired Cholesteatoma in Children

Chin-Lung Kuo,An-Suey Shiao,Wen-Huei Liao,Chiang-Feng Lien
DOI: https://doi.org/10.1177/0194599814541627a247
2014-09-01
Otolaryngology–Head and Neck Surgery
Abstract:Objectives: A CAO (cholesteatoma extent, atelectasis degree and ossicle involvement) staging system for cholesteatoma was described at the XIII World Congress of Otorhinolaryn-gology in Florida in 1985. Because of 30 years of accumulated clinical data, we propose a revised and simplified model of stratification. This study aimed to investigate the prognosis of pediatric acquired cholesteatoma based on this revised staging system. Methods: Between 1982 and 2012, 132 ears in 128 children (≤18 years of age) with acquired cholesteatomas after primary surgery were included. Each case was scored for cholesteatoma extent, history of grommet insertion, age, ossicular destruction, and otorrhea. The total score classified the patients as stage I (5-6 points), stage II (7-9 points) or stage III (10-12 points). The staging system was applied to the first (66 ears) and second (66 ears) halves of the cohort, and the entire cohort (132 ears). Differences between stages were compared using Kaplan-Meier cumulative recidivism curves. Results: The mean follow-up period was 12 years. The 15-year cumulative recidivism rate was 19.6% overall, 0% in stage I, 10.4% in stage II, and 30.6% in stage III. The cumulative recidivism curves were well stratified by stage, with differences reaching statistical significance in the second half and entire cohort ( P = .048 and .026, respectively). Conclusions: The proposed revised staging classification may adequately stratify patients regarding the prognosis, facilitating the identification of children at risk of recidivism. Further external validation on an independent data set is warranted before broad application can be recommended.
What problem does this paper attempt to address?